AbbVie has inflammatory bowel illness coated with blockbuster medication now in the marketplace and extra drug candidates in medical improvement. The pharmaceutical large is diversifying its IBD prospects and gaining one other candidate by means of the acquisition of Celsius Therapeutics, a clinical-stage startup whose lead program presents a special strategy to treating irritation. Beneath the phrases of the deal, […]
